ALPA vs NGLFINE: Stock Comparison

Alpa Laboratories Limited vs NGL Fine-Chem Limited

Live data: 22 July 2026, 2:58 PM IST • Source: NSE and company filings

NGL Fine-Chem Limited is the larger company by market capitalisation. Alpa Laboratories Limited shows a lower P/E, lower leverage and a higher net margin, while NGL Fine-Chem Limited shows a higher ROE, a higher dividend yield and faster revenue growth. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Side-by-side comparison of Alpa Laboratories Limited and NGL Fine-Chem Limited on live price, valuation, growth, profitability, leverage and quarterly shareholding. Highlighted values mark the more favourable of the two on that metric's usual reading; a single metric is never the full story.

On standard readings, ALPA is more favourable on 4 of 13 scored metrics and NGLFINE on 9These counts are context-free and are not an overall rating.

Key Differences

Market Cap
NGLFINE is the larger company
₹2,008 Cr vs ₹142 Cr
P/E Ratio
ALPA has a lower P/E
12.09x vs 41.23x
P/B Ratio
ALPA has a lower P/B
0.77x vs 6.03x
EPS
NGLFINE has higher earnings per share
₹78.04 vs ₹7.14
Dividend Yield
NGLFINE has a higher dividend yield
0.05% vs 0%
Revenue Growth (TTM YoY)
NGLFINE has faster revenue growth
57.2% vs -21.4%
EPS Growth (TTM YoY)
NGLFINE has faster EPS growth
1,539.8% vs 0%
Qtr Sales Growth
NGLFINE has stronger quarterly sales growth
57.1% vs -21.3%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricALPANGLFINE
SectorHealthcareHealthcare
IndustryPharmaceuticalsPharmaceuticals

Price

MetricALPANGLFINE
Live Price₹66.98₹3,252.2
Day Change-0.98%0.46%
Volume6,9585,218
52-Week High₹105.51₹3,329
52-Week Low₹46.1₹1,175.5
Distance from 52W High-36.52%-2.31%

Valuation

MetricALPANGLFINE
Market Cap₹142 Cr₹2,008 Cr
P/E Ratio12.09x41.23x
P/B Ratio0.77x6.03x
EPS₹7.14₹78.04
Book Value₹32.34₹532.95
Dividend Yield0%0.05%

Growth

MetricALPANGLFINE
Revenue Growth (TTM YoY)-21.4%57.2%
EPS Growth (TTM YoY)0%1,539.8%
Qtr Sales Growth-21.3%57.1%
Qtr Profit Growth165%2,398%

Profitability & Leverage

MetricALPANGLFINE
ROE8.39%15.7%
ROCE9.42%17%
Net Margin14.33%9.59%
Operating Margin3.11%14.5%
Debt to Equity0.01x0.33x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricALPANGLFINE
Promoter Holding57.19%72.74%
FII Holding0.35% 0.03 pp0.03% 0.03 pp
DII Holding0.07% 0.07 pp0%
Public Holding42.39% 0.04 pp27.24% 0.02 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: Alpa Laboratories Limited and NGL Fine-Chem Limited.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.